2020 Oxygen Radicals Gordon Research Conference (GRC) and Gordon Research Seminar (GRS)
2020 Oxygen Radicals Gordon Research Conference (GRC) and Gordon Research Seminar (GRS)
批准号:
9912443
负责人:
Yvonne M. W. Janssen-Heininger
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-22 至 2021-01-21
关键词:
AcademiaAddressAgeAgingApplications GrantsApplied ResearchAreaAtmosphereAwardBasic ScienceBiologyCaliforniaCell physiologyCessation of lifeChemicalsChemistryCollaborationsCommunicationCountryDiagnosticDiseaseElevatorEndoplasmic ReticulumEnsureEnvironmentEthnic OriginEventFDA approvedFailureFertilizationFosteringFree RadicalsFunctional disorderFundingFutureGenderGoalsGovernmentHealthHomeostasisHourIllinoisIncentivesIndustryIronKnowledgeLinkLipidsLocationMedicineMetabolicMetabolismMethodologyMitochondriaNationalitiesOralOrganellesOxidantsOxidation-ReductionParticipantPharmaceutical PreparationsPlayPoliciesPost-Translational Protein ProcessingPostdoctoral FellowPublished CommentReactive Oxygen SpeciesRegulationResearchResearch PersonnelResearch Project GrantsRheaRoleRunningScientistSenior ScientistSocial PlanningStudentsTherapeuticTranslationsTravelTwitterUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUniversitiesVermontWomanbasecareercareer developmentclinical developmentcostdrug developmenteducational atmosphereexperiencegraduate studenthealthspaninnovationinquiry-based learninglecturesmeetingsnovelpeerpostersprogramsproteostasisresponsesenescencesensorsocialstem cellssymposiumtherapeutic developmenttooltumor metabolism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This conference grant proposal seeks funds for a Gordon Research Conference (GRC) on Oxygen Radicals:
Chemical Reactivity, Metabolism, and Opportunities for Therapeutic Development to be held in Ventura CA
February 2-7, 2020, in conjunction with a Gordon Research Seminar (GRS) for trainees, organized by two
trainees (Cheryl van de Wetering, and Rhea Bovee), to be held immediate prior to the GRC, February 1-2, 2020
at the same location. We present an exciting program that brings together diverse fields of oxidant research,
integrating recent discoveries of new oxidant species, with methodological advances, studies of biology,
organelle dysfunction and metabolism, and aging, and plenary and round table discussions focusing on redox-
based drugs in clinical development. The program includes senior scientists (giving the keynote lectures), as
was as junior and mid-career scientists, and we have 10 slots for invited talks from submitted abstracts. Speakers
are from academia, industry and the NIH, represent 19 countries and will be sharing their latest discoveries in
nine sessions: Keynote session I: Oxygen Radicals: connecting chemistry with biology and medicine;
Mitochondria from energy power houses to metabolite regulators; Oxygen radicals in stem cell function,
senescence and aging; Redox in translation: Hurdles and ways forward toward therapeutics; Endoplasmic
reticulum-redox control of proteostasis and dysregulation in disease; Reactive lipids in death, homeostasis and
as therapeutics: Ferroptosis, and beyond; Advances in redox sensors, probes, and diagnostics; Oxygen radicals
in metabolism; Keynote session II: Technical advances in the study of oxygen radicals; opportunities and
challenges. Other conference highlights are the power hour and representation by women with a twitter feed
#REDOXWOMEN and assurance that at least 40% of all presenters or discussion leaders are women. We will
have elevator pitch sessions to highlight posters, and a policy of first questions by trainees. We will have welcome
tables and social events to be inclusive of new attendees and continue the tradition of the Iron Bolt Award for
the most notable comment. Collectively, this program will ensure a vibrant and collegial atmosphere to share the
top discoveries in research on oxygen radicals, their involvement in disease and aging and potential avenues for
therapeutic development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glutaredoxin, Glutathione Metabolism and Lung Cancer
-
批准号:10657945
-
项目类别:
-
资助金额:$53.51万
-
财政年份:2023
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Collagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis
-
批准号:10532853
-
项目类别:
-
资助金额:$48.29万
-
财政年份:2022
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Collagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis
-
批准号:10445737
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2021
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
S-glutathionylation chemistry in fibrotic lung remodeling
-
批准号:10585922
-
项目类别:
-
资助金额:$92.76万
-
财政年份:2017
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
S-glutathionylation chemistry in fibrotic lung remodeling
-
批准号:10320789
-
项目类别:
-
资助金额:$92.79万
-
财政年份:2017
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas signaling in allergic airway disease
-
批准号:7822474
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2009
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
-
批准号:7367482
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2008
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
-
批准号:7644952
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2008
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox Biology in COPD
-
批准号:7690866
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2008
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
-
批准号:8459777
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2008
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
-
批准号:7808797
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2008
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
-
批准号:8792545
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2008
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas Signaling in Allergic Airway Disease
-
批准号:7739292
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas signaling in allergic airway disease
-
批准号:6858086
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas signaling in allergic airway disease
-
批准号:6988549
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas signaling in allergic airway disease
-
批准号:7325700
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas Signaling in Allergic Airway Disease
-
批准号:9038404
-
项目类别:
-
资助金额:$40.17万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas Signaling in Allergic Airway Disease
-
批准号:8829884
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas Signaling in Allergic Airway Disease
-
批准号:8307763
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
Redox-based Fas Signaling in Allergic Airway Disease
-
批准号:8710886
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2004
-
负责人:Yvonne M. W. Janssen-Heininger
-
依托单位:
海外基金